Cargando…
Expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: Vascular endothelial growth factor receptor 2
Antibodies and their derivative fragments have long been used as tools in a variety of applications, in fundamental research work, biotechnology, diagnosis, and therapy. Camels produce single heavy-chain antibodies (VHH) in addition to usual antibodies. These minimal-sized binders are very robust an...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544076/ https://www.ncbi.nlm.nih.gov/pubmed/23326765 http://dx.doi.org/10.4103/2277-9175.100126 |
_version_ | 1782255740231090176 |
---|---|
author | Behdani, Mahdi Zeinali, Sirous Karimipour, Morteza Khanahmad, Hossein Asadzadeh, Nader Azadmanesh, Kayhan Seyed, Negar Baniahmad, Seyed Farzad Anbouhi, Mahdi Habibi |
author_facet | Behdani, Mahdi Zeinali, Sirous Karimipour, Morteza Khanahmad, Hossein Asadzadeh, Nader Azadmanesh, Kayhan Seyed, Negar Baniahmad, Seyed Farzad Anbouhi, Mahdi Habibi |
author_sort | Behdani, Mahdi |
collection | PubMed |
description | Antibodies and their derivative fragments have long been used as tools in a variety of applications, in fundamental research work, biotechnology, diagnosis, and therapy. Camels produce single heavy-chain antibodies (VHH) in addition to usual antibodies. These minimal-sized binders are very robust and bind the antigen with high affinity in a monomeric state. Vascular endothelial growth factor recepror-2 (VEGFR2) is an important tumor-associated receptor that blockade of its signaling can lead to the inhibition of neovascularization and tumor metastasis. Here, we describe the construction, expression, and purification VEGFR2-specific Diabody. Two variable fragments of a same camel anti-VEGFR2 antibody were linked together by the upper hinge segment of antibody to make a diabody. We showed the ability of diabody to recognition of VEGFR2 on the cell surface by FACS. Diabodies can be produced in the low-cost prokaryotic expression system, so they are suitable molecules for diagnostic and therapeutic issues. |
format | Online Article Text |
id | pubmed-3544076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-35440762013-01-16 Expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: Vascular endothelial growth factor receptor 2 Behdani, Mahdi Zeinali, Sirous Karimipour, Morteza Khanahmad, Hossein Asadzadeh, Nader Azadmanesh, Kayhan Seyed, Negar Baniahmad, Seyed Farzad Anbouhi, Mahdi Habibi Adv Biomed Res Original Article Antibodies and their derivative fragments have long been used as tools in a variety of applications, in fundamental research work, biotechnology, diagnosis, and therapy. Camels produce single heavy-chain antibodies (VHH) in addition to usual antibodies. These minimal-sized binders are very robust and bind the antigen with high affinity in a monomeric state. Vascular endothelial growth factor recepror-2 (VEGFR2) is an important tumor-associated receptor that blockade of its signaling can lead to the inhibition of neovascularization and tumor metastasis. Here, we describe the construction, expression, and purification VEGFR2-specific Diabody. Two variable fragments of a same camel anti-VEGFR2 antibody were linked together by the upper hinge segment of antibody to make a diabody. We showed the ability of diabody to recognition of VEGFR2 on the cell surface by FACS. Diabodies can be produced in the low-cost prokaryotic expression system, so they are suitable molecules for diagnostic and therapeutic issues. Medknow Publications & Media Pvt Ltd 2012-08-28 /pmc/articles/PMC3544076/ /pubmed/23326765 http://dx.doi.org/10.4103/2277-9175.100126 Text en Copyright: © 2012 Behdani http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Original Article Behdani, Mahdi Zeinali, Sirous Karimipour, Morteza Khanahmad, Hossein Asadzadeh, Nader Azadmanesh, Kayhan Seyed, Negar Baniahmad, Seyed Farzad Anbouhi, Mahdi Habibi Expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: Vascular endothelial growth factor receptor 2 |
title | Expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: Vascular endothelial growth factor receptor 2 |
title_full | Expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: Vascular endothelial growth factor receptor 2 |
title_fullStr | Expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: Vascular endothelial growth factor receptor 2 |
title_full_unstemmed | Expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: Vascular endothelial growth factor receptor 2 |
title_short | Expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: Vascular endothelial growth factor receptor 2 |
title_sort | expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: vascular endothelial growth factor receptor 2 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544076/ https://www.ncbi.nlm.nih.gov/pubmed/23326765 http://dx.doi.org/10.4103/2277-9175.100126 |
work_keys_str_mv | AT behdanimahdi expressionpurificationandcharacterizationofadiabodyagainstthemostimportantangiogenesiscellreceptorvascularendothelialgrowthfactorreceptor2 AT zeinalisirous expressionpurificationandcharacterizationofadiabodyagainstthemostimportantangiogenesiscellreceptorvascularendothelialgrowthfactorreceptor2 AT karimipourmorteza expressionpurificationandcharacterizationofadiabodyagainstthemostimportantangiogenesiscellreceptorvascularendothelialgrowthfactorreceptor2 AT khanahmadhossein expressionpurificationandcharacterizationofadiabodyagainstthemostimportantangiogenesiscellreceptorvascularendothelialgrowthfactorreceptor2 AT asadzadehnader expressionpurificationandcharacterizationofadiabodyagainstthemostimportantangiogenesiscellreceptorvascularendothelialgrowthfactorreceptor2 AT azadmaneshkayhan expressionpurificationandcharacterizationofadiabodyagainstthemostimportantangiogenesiscellreceptorvascularendothelialgrowthfactorreceptor2 AT seyednegar expressionpurificationandcharacterizationofadiabodyagainstthemostimportantangiogenesiscellreceptorvascularendothelialgrowthfactorreceptor2 AT baniahmadseyedfarzad expressionpurificationandcharacterizationofadiabodyagainstthemostimportantangiogenesiscellreceptorvascularendothelialgrowthfactorreceptor2 AT anbouhimahdihabibi expressionpurificationandcharacterizationofadiabodyagainstthemostimportantangiogenesiscellreceptorvascularendothelialgrowthfactorreceptor2 |